Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Likar, R; Koestenberger, M; Stultschnig, M; Nahler, G.
Concomitant Treatment of Malignant Brain Tumours With CBD - A Case Series and Review of the Literature.
Anticancer Res. 2019; 39(10):5797-5801 Doi: 10.21873/anticanres.13783
Web of Science PubMed FullText FullText_MUG

 

Leading authors Med Uni Graz
Likar Rudolf
Co-authors Med Uni Graz
Köstenberger Markus
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Grade IV glioblastoma multiforme is a deadly disease, with a median survival of around 14 to 16 months. Maximal resection followed by adjuvant radiochemotherapy has been the mainstay of treatment since many years, although survival is only extended by a few months. In recent years, an increasing number of data from in vitro and in vivo research with cannabinoids, particularly with the non-intoxicating cannabidiol (CBD), point to their potential role as tumour-inhibiting agents. Herein, a total of nine consecutive patients with brain tumours are described as case series; all patients received CBD in a daily dose of 400 mg concomitantly to the standard therapeutic procedure of maximal resection followed by radiochemotherapy. By the time of the submission of this article, all but one patient are still alive with a mean survival time of 22.3 months (range=7-47 months). This is longer than what would have been expected.
Find related publications in this database (using NLM MeSH Indexing)
Adolescent - administration & dosage
Adult - administration & dosage
Brain Neoplasms - drug therapy, mortality, therapy
Cannabidiol - therapeutic use
Chemoradiotherapy, Adjuvant - methods
Child, Preschool - administration & dosage
Combined Modality Therapy - methods
Female - administration & dosage
Glioblastoma - drug therapy, mortality, therapy
Humans - administration & dosage
Male - administration & dosage
Middle Aged - administration & dosage
Survival Rate - administration & dosage

Find related publications in this database (Keywords)
Cannabidiol
cannabinoids
chemoradiation
brain tumours
glioblastoma multiforme
© Med Uni GrazImprint